Skip to main content

Table 2 Exploratory clinical and biomarker outcomes (n = 21)

From: Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data

 

Baseline

Follow-up

P

NT-proBNP, pg/ml

3873 ± 3140

1945 ± 1860

0.009

NYHA class

2.9 ± 0.4

2.3 ± 0.6

0.001

  1. Abbreviations: NT-proBNP N-terminal pro B-type natriuretic peptide, NYHA New York Heart Association
Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us